Mount Sinai Beth Isreal — New York, New York

Mount Sinai Beth Isreal is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Beth Isreal has participated in 1 clinical trials.

Therapeutic areas: Primary Biliary Cholangitis.

Sponsors: Enanta Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Beth Isreal?

Mount Sinai Beth Isreal has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Beth Isreal conducted?

Mount Sinai Beth Isreal has 1 clinical trials on record. Their work covers Primary Biliary Cholangitis.

Is Mount Sinai Beth Isreal accredited by Crixeo Health?

Mount Sinai Beth Isreal has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Beth Isreal?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.